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AbstrACt
Objectives The Lancet Commission on Global Surgery 
estimated that low/middle-income countries will lose 
an estimated cumulative loss of US$12.3 trillion from 
gross domestic product (GDP) due to the unmet burden 
of surgical disease. However, no country-specific data 
currently exist. We aimed to estimate the costs to the 
Sierra Leone economy from death and disability which 
may have been averted by surgical care.
Design We used estimates of total, met and unmet 
need from two main sources—a cluster randomised, 
cross-sectional, countrywide survey and a retrospective, 
nationwide study on surgery in Sierra Leone. We 
calculated estimated disability-adjusted life years from 
morbidity and mortality for the estimated unmet burden 
and modelled the likely economic impact using three 
different methods—gross national income per capita, 
lifetime earnings foregone and value of a statistical life.
results In 2012, estimated, discounted lifetime losses 
to the Sierra Leone economy from the unmet burden of 
surgical disease was between US$1.1 and US$3.8 billion, 
depending on the economic method used. These lifetime 
losses equate to between 23% and 100% of the annual 
GDP for Sierra Leone. 80% of economic losses were due 
to mortality. The incremental losses averted by scale up 
of surgical provision to the Lancet Commission target of 
80% were calculated to be between US$360 million and 
US$2.9 billion.
Conclusion There is a large economic loss from the 
unmet need for surgical care in Sierra Leone. There is an 
immediate need for massive investment to counteract 
ongoing economic losses.
IntrODuCtIOn  
Although once described as the ‘neglected 
stepchild of global health’,1 surgery is increas-
ingly being recognised as an indivisible, 
indispensable part of healthcare.2 Currently, 
surgical disease accounts for an estimated 33% 
of the global burden of disease,3 with an esti-
mated 5 billion people have no access to safe, 
affordable surgical care and anaesthesia when 
needed4 and an estimated 143 million addi-
tional procedures needed in low/middle-in-
come countries (LMICs) to save lives and to 
prevent disability.5 Surgical access is weakest 
in low-income countries.6 Although tradition-
ally thought of as an expensive intervention, 
cost-effectiveness analyses have shown that 
surgeries—both individual procedures and 
surgical platforms—are cost-effective when 
compared with other widely implemented 
health interventions.7 
A number of studies have shown the 
profound economic impact on individuals 
and households resulting from untreated 
surgical conditions, with resulting death 
and disability.8 9 However, treatment of such 
conditions can improve the quality of life, 
household income as well as social status.10 
Reducing deaths and disability from road 
traffic accidents alone in LMICs to the level 
of high-income countries would result in 
a potential economic saving of US$758–
786 billion per year.11 If there is no accel-
erated urgent scale up of surgical services, 
LMICs are estimated to lose a cumulative 
US$12.3 trillion to their economies over the 
next 15 years.5
To date, there have been no country-spe-
cific estimates of the economic costs resulting 
from loss of productivity due to death and 
disability from surgically treatable disease. 
Sierra Leone has been estimated to have a 
strengths and limitations of this study
 ► The Lancet Commission on Global Surgery estimated 
cumulative losses from unmet surgical need of 
US$12.3 trillion globally. This is the first country-
specific study to estimate macroeconomic losses.
 ► Estimates of unmet need in this study are based 
on previous studies. It is not possible to be certain 
exactly what the unmet surgical need is.
 ► Likewise, true death and disability averted is 
impossible to be accurately determined and is based 
on estimates.
 ► All modelling strategies have their limitations, 
especially in resource-poor settings. Therefore, we 
used three different approaches for comparison.
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high burden of surgical disease, with a household survey 
suggesting that 25% of deaths in the previous year may 
have been averted by timely surgical intervention, and 
25% of respondents claiming to have a surgical condi-
tion requiring attention.12 Results from a national survey 
reported that there were 24 152 operations in Sierra 
Leone in 2012 across all hospitals (government and 
private) amounting to a national average of 400 opera-
tions per 100 000. This amounts to approximately 8% of 
surgical disease treated and 92% untreated. Our aim was 
to estimate the likely impact on the Sierra Leonean gross 
domestic product (GDP) resulting from this untreated 
surgical disease.
This study is carried out in the context of slow improve-
ments in health and economic indicators for Sierra 
Leone compared with other West African countries. 
Although life expectancy at birth increased from 41 to 51 
years between 2002 and 2014, this remains the lowest life 
expectancy of any country assessed by WHO.13 Malnutri-
tion, communicable diseases and poor maternal and child 
health services cause substantial mortality and morbidity 
each year.14 The country has a growing and youthful 
population driven by a high total fertility rate of almost 
five children per woman, yet a small and largely agrarian 
economy underuses this potential of its workforce with 
an estimated 60% youth unemployment attributable 
to poor educational outcomes, a lack of private sector 
jobs and low pay.15 Sierra Leone ranks 179 out of 188 
countries included in the United Nations Development 
Programme’s Human Development Index, a composite 
ranking of health, educational and economic outcomes 
by country.16
MethODs
Disability-adjusted life year
The disability-adjusted life year (DALY) is a composite 
measure of health quantity and quality which seeks 
to capture the negative consequences of premature 
mortality alongside burden from morbidity for the dura-
tion of an illness:
 DALYs = YLD + YLL (1)
 YLD = I× D× DW (2)
 YLL = N× LD (3)
where YLD is the number of years lost due to disability, 
I the incidence of a condition, D the duration of illness, 
DW the disability weight, YLL the years of life lost, N the 
number of deaths from a condition and LD the life expec-
tancy at age of death. DALYs are sometimes weighted 
differently according to the age at which a person dies in 
theory to reflect societal values around death at younger 
age. This is a controversial topic in the calculation of 
DALYs and, as in WHO Global Burden of Disease (GBD) 
studies since 2001, we do not apply age weighting in this 
analysis. We used local life expectancies from WHO’s Life 
Table for Sierra Leone in 201213 and disability weights 
published by the GBD Study.17
Details of all operations performed in Sierra Leone in 
2012 from every surgical provider was obtained from a 
nationwide, retrospective study.18 Data were excluded if 
there was no recorded age for the patient or no recorded 
operation. The remaining records were then analysed. 
For each operation, we used a weighting system used by 
previous authors19 20 to determine the likely threat to life 
without treatment, the likelihood of permanent disability 
and the likely efficacy of treatment (table 1). Operations 
were deemed to either avert death or disability as in 
table 2. Weights for each operation were estimated using 
a Delphi method of local doctors and experts in each 
field. Operations were weighted differently depending on 
whether they were ‘emergency’ or ‘planned’ operations. 
Those where it was unclear whether it was performed as 
a planned or an emergency operation were weighted as 
for a ‘planned’ operation. Assumptions for each oper-
ation are shown in table 2. Disability weights for condi-
tions primarily causing disability were obtained from the 
Global Burden of Disease Study.17
Methods for calculating economic losses
A number of methods are available to calculate economic 
losses due to preventable health conditions, and we opt to 
take three approaches which are simple and transparent 
in nature.
Acknowledging the breadth of literature in this area, we 
use three different approaches to estimate productivity 
losses from unmet surgery need: two applying the human 
capital approach (HCA), first using inputs of GDP/
capita and second lifetime earnings forgone, alongside a 
method incorporating the value of a statistical life.
Both HCA approaches use national accounts or work-
force participation and earnings data and do not require 
extensive assumptions around the structure of the Sierra 
Leonean economy. These methods may therefore under-
estimate economic losses because they do not capture 
dynamic effects of reductions in morbidity or mortality, 
Table 1 Weightings definition
Weighting 
given Risk of death or permanent disability Treatment efficacy
0 Condition fatal or permanently disabling <5% of the time <5% chance of permanent cure
0.3 Condition fatal or permanently disabling 5%–50% of the time 5%–50% chance of permanent cure
0.7 Condition fatal or permanently disabling 50%–95% of the time 50%–95% chance of permanent cure
1 Condition fatal or permanently disabling >95% of the time >95% chance of permanent cure
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for example, the economic productivity from additional 
children of persons whose death is delayed by surgery. 
The methods are consistent with the growing consensus 
in health economic evaluation that the societal perspec-
tive should be considered where possible to give a more 
accurate reflection of true economic losses to society, 
outside of direct health expenditure.21
The value of a statistical life (VSL) is the amount of 
money a person or society is willing to spend to save one 
life and is commonly used by public bodies to value lives 
saved in cost–benefit analyses of health, transport or envi-
ronmental projects.22 Data often come from the labour 
market, where individuals sometimes make decisions 
that involve a trade-off between financial rewards and an 
increased risk of premature mortality. Economists use 
this revealed preference for risk to calculate their VSL, 
reflecting the amount individuals are willing to pay to 
avert the risk of dying. For example, if a welder on an oil 
rig was willing to accept a pay cut of £1000 to work on land 
where the risk of death was 0.001 lower, their VSL would 
be £1 million (£1000/0.001). VSL estimates are often 
larger than production-based measures of welfare losses 
(including the HCA) but fit better into welfare economic 
frameworks because they allow the worth of individuals to 
be greater than their wage rate.
We present economic losses both as an absolute 
number for income loss discounted to 2014 US$ and as 
a percentage of GDP; however, we note caution in inter-
preting the latter. Household earnings (and subsequent 
consumption) are elements of GDP calculations, along-
side aggregate government expenditure and business 
investment, among others. As elsewhere in the litera-
ture,23 we use the comparison between projected losses 
and actual GDP as a useful relative frame to understand 
the large numbers produced by this model. However, we 
emphasise that these are not directly causal and, in fact, 
may understate the direct effect of unmet surgery need 
on GDP. Finally, we compare figures to the 2014 GDP of 
Sierra Leone due to the anticipated negative impact of 
Ebola virus disease on the Sierra Leonean economy.24
Table 2 Delphi weights for primarily death-averting and primarily disability-averting operations with assumptions on earnings
Threat to 
life
Treatment 
efficacy
Risk of 
permanent 
disability Assumption on earnings
Primarily death averting
  Appendectomy 0.7 1.0
  Caesarian section 0.3 0.7
  Cervical or vaginal laceration 0.1 1.0
  Chest tube 1.0 1.0
  Dilatation and curettage 0.3 0.7
  Hernia repair (emergency) 0.7 1.0
  Hysterectomy 0.3 0.7
  Laparotomy—emergency 1.0 0.7
  Laparotomy—elective 0.3 0.3
  Malignancy 1.0 0.3
  Manual placenta removal 0.3 0.7
  Neonatal surgery (emergency) 1.0 0.7
  Repair of ruptured uterus 1.0 1.0
  Ectopic pregnancy 0.7 1.0
  Tracheostomy 1.0 0.7
  Amputation of limb 1.0 0.7
Primarily disability averting
  Cataract surgery 0.7 0.7 60% lifetime earnings lost
  Cleft lip repair 0.7 1.0 No impact (no literature found)
  Cystostomy 1.0 0.7 No impact (no literature found)
  Fracture 0.7 0.7 88% of earnings lost for 1 year
  Hernia repair (planned/unknown) 0.3 1.0 18% (16%–20%) lifetime earnings lost
  Neonatal surgery (planned/unknown) 0.7 0.7 No impact (no literature found)
  Obstetric fistula repair 0.7 1.0 97% lifetime earnings lost
  Urethral stricture dilation 0.3 1.0 No impact
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Modelling approach
The need for surgery in Sierra Leone was calculated from 
two cluster randomised, cross-sectional, countrywide 
surveys.12 25 First, we generate a counterfactual scenario 
where all annual mortality and disability is avoided by 
assuming current met need is 8%, as estimated by Bolkan 
et al,18 although this is likely to be a conservative esti-
mate. Then, we present different scenarios of met need 
according to published studies and benchmarks, aggre-
gating reductions in mortality and morbidity separately.
The literature has not reached consensus on how to 
estimate productivity losses due to morbidity.22 We take 
a pragmatic approach and obtain condition-specific data 
from the literature to estimate the proportion of persons 
with surgically treatable conditions who were unable to 
work following the development of a condition (table 2). 
Where no evidence of productivity effects are noted, we 
take a conservative approach and assume that untreated 
persons do not suffer productivity losses. Further infor-
mation is provided in online supplementary file 1.
estIMAtIOn Of eCOnOMIC lOsses
We use three methods to estimate economic losses:
Gross national income per capita
A common application of the HCA, recommended by the 
WHO Commission on Macroeconomics and Health, is to 
use gross national income (GNI) per capita to estimate 
the potential economic gains from gaining an additional 
year of life.26 This approach has been applied elsewhere 
to estimate economic gains and losses of health interven-
tions. Although the GNI/capita approach may undervalue 
benefits from averting a DALY as it does not account for 
externalities on the wider labour market or care required 
from family members, the method is transparent and 
broadly accepted in the literature.22 Thus, GNI/capita 
approximates the economic value that the average indi-
vidual adds to a society per year, and we simply multiply 
GNI/capita by the number of DALYs averted in each 
scenario of met surgical need.
lifetime earnings forgone
The GNI/capita approach does not necessarily equate to 
the majority of individuals’ economic productivity, partic-
ularly in unequal economies such as Sierra Leone, where 
few very productive individuals may bias mean earning 
estimates. Therefore, we calculate the present value of 
lifetime earnings (PVLE) forgone for each age category, 
slightly adapting the model presented in Menzin et al.27
 PVLEpaid(i, j, k) =
nj∑
i=sj
(
li,j,k∗wi,j,k
)(
1+r
)i−sj  (4)
where the estimated losses for a cohort of persons with 
age i, gender j, working in employment sector k and with 
life expectancy sj are a weighted average of their economic 
activity, l, and wage rate w. We split each gender into five 
age groups, driven by the availability of data on avertable 
mortality and morbidity and use the midpoint of each 
strata to estimate years of productive life remaining.
We use data from the nationally representative 2011 
Sierra Leone Integrated Household Survey (SLIHS)28 to 
obtain estimates of labour force participation by gender. 
We estimate the proportion of the population not in the 
labour force, the proportion employed in agriculture 
and the proportion in other waged industry. For both 
employed groups, we use SLIHS data to calculate the 
number of hours worked per year and apply earnings and 
salary data to estimate total annual earnings.
Value of a statistical life
A number of methods exist to calculate the VSL in Sierra 
Leone, which are briefly summarised in online supple-
mentary table 1. For our main analysis, we use $90 700 
as calculated for sub-Saharan Africa by Robinson and 
Hammit.29 We follow Alkire et al30 and convert this VSL 
Table 3 Total number of disability-adjusted life years 
averted by operation
No of operations 
in 2012
Primarily death averting
  Amputation 234
  Appendectomy 1114
  Caesarian section 2646
  Cervical or vaginal laceration 24
  Chest tube 35
  Dilatation and curettage 508
  Hernia repair (emergency) 166
  Hysterectomy (all) 218
  Laparotomy (all) 815
  Malignancy 173
  Manual placenta removal 65
  Necrosectomy 1
  Neonatal surgery (emergency) 13
  Manual placenta removal 8
  Salpingectomy for ectopic pregnancy 10
  Ectopic pregnancy 103
  Tracheostomy 8
Primarily disability averting
  Cataract surgery 2242
  Cleft lip repair 2
  Cystectomy 16
  Fracture 964
  Hernia repair (planned/unknown) 3435
  Neonatal surgery (planned/unknown) 5
  Obstetric fistula repair 201
  Urethral stricture dilation 59
Total 13 065
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into its annualised equivalent, the value of a statistical 
life year, for use with DALYs. Here, we assume that the 
VSL is analogous to an annuity, giving a constant stream 
of income of $31 415 per year (5% discount rate). 
Consistent with DALY calculations, we do not apply age 
weighting to this value so assume it remains constant 
throughout a lifetime. The use of Sierra Leonean data 
negates the rescaling of VSL from the USA, as else-
where.29 31
Discount rate
The choice of discount rate can have a large impact on 
the results of an economic analysis, particularly when 
benefits or costs occur a long time after initial expendi-
ture.32 We use a discount rate of 5% on costs and benefits. 
We explore the effect of higher discount rates in a sensi-
tivity analysis.
uncertainty and sensitivity analyses
We use a deterministic sensitivity analysis to explore 
methodological uncertainty stemming from the choice 
of discount rate, exploring a zero discount rate, 3% as 
per guidelines and 8.7% to mirror the local inflation rate. 
We carry out a multivariate probabilistic sensitivity anal-
ysis with 1000 Monte Carlo simulations of a number of 
variables simultaneously to assess the impact of parameter 
uncertainty on model predictions and present included 
parameters and distributional assumptions in online 
supplementary table 2.
results
Met need in 2012
Out of the 24 152 operations recorded as being performed 
in Sierra Leone in 2012, 46% were excluded—5672 
because of a lack of detail about the operation and 5415 
because there was no age recorded. We assumed that the 
54% analysed were representative of the unmet need. Of 
the remaining operations, 6141 were death averting and 
6924 were disability averting (table 3). Accounting for 
the probability of success in death-averting operations, 
2219 deaths were averted through surgical intervention 
in 2012 (table 4).
health losses due to unmet need
Assuming that the 24 152 operations recorded in 2012 
represent 7.9% of met surgical need in Sierra Leone,18 
we estimate that unmet surgical need in 2012 resulted 
in 766 606 DALYs forgone: 606 981 DALYs lost due to 
mortality and 159 625 due to morbidity. If surgical provi-
sion could be increased to 80% in line with the recom-
mendations of the Lancet Commission on Global Surgery, 
an additional 599 953 DALYs would be averted compared 
with 2012 provision. Reaching the goal of 50% provision 
would avert an additional 349 972 DALYs, while the prag-
matic target of 20% provision would result in 99 992 addi-
tional DALYs averted.
economic losses
Figure 1 presents estimated discounted economic losses 
from unmet surgery need. As anticipated, using different 
approaches to estimate losses, resulted in vastly different 
figures. The value of a statistical life approach gave the 
highest figure: current economic losses due to unmet 
surgery need were estimated to be $3.8 billion (all mone-
tary figures presented as 2012 US$), equivalent to 107% 
of Sierra Leone’s GDP in 2012. The GNI/capita approach 
put forward by the WHO Macroeconomic Commission 
gave the next highest figure of $1.4 billion (42% of 2012 
GDP), while the lifetime earnings forgone method gave 
an estimate of $1.1 billion (31% of 2012 GDP). Economic 
losses due to mortality contributed to around 80% of 
total economic loss from unmet need across all measures. 
Finally, table 5 presents the incremental losses that would 
be averted if surgical provision were to be scaled up to 
each of the three target scenarios.
sensitivity analyses
Figure 2 displays results from a one-way sensitivity anal-
ysis, analysing the change in estimates of unmet need as 
model parameters are varied in isolation. Estimates are 
particularly sensitive to assumptions of current unmet 
need and whether the productivity estimates consider 
morbidity in addition to mortality. Assumptions of earn-
ings do not make a substantive difference to estimates 
using the lifetime earnings forgone method.
Figure 3 displays the results of a probabilistic sensi-
tivity analysis alongside base case estimates, while error 
bars illustrate the 25th and 75th quartiles of Monte Carlo 
model runs. When accounting for parameter uncertainty 
in the Probabilistic Sensitivity Analysis (PSA), the model 
still predicts substantial economic losses due to unmet 
surgical need. Of all probabilistic simulations, 38% of esti-
mates were greater than the deterministic estimate. The 
variability of VSL simulation estimates is between 61% 
and 73% greater than that of human capital approaches.
DIsCussIOn
In 2013, the Lancet Commission on Investing in 
Health argued that investing in healthcare in LMICs 
produced profound returns on investment of between 
Table 4 Summary of met surgical need in 2012
Age 
(years)
Deaths 
averted 
in 2012
Mortality DALYs 
averted due to 
surgery in 2012 (YLL)
Morbidity DALYs 
averted due to 
surgery in 2012 (YLD)
1–4 58 1073 293
5–15 214 3877 741
16–19 278 4936 566
20–33 778 13 086 2225
34+ 332 5173 3626
DALYs, disability-adjusted life years; YLD, years lost due to 
disability; YLL, years of life lost.
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US$9 and US$20 for every dollar invested.33 The ques-
tion thus arose as to whether investment in the provision 
of surgical services to avert death and disability would 
give a similar financial return on investment. This ques-
tion was addressed by the Lancet Commission on Global 
Surgery which presented data on both the economic 
impact of untreated disease and the financial commit-
ment required to scale up surgical services. Alkire et al 
calculated projected economic losses in LMICs from 
a variety of surgical conditions using the value of lost 
output approach of up to 2.5% of annual GDP and 17% 
of 2010 GDP if a value of lost welfare approach was used.34 
Verguet et al35 modelled the possible scale up of surgical 
services in LMICs for the Lancet Commission on Global 
Surgery target of 5000 operations per 100 000 population 
per year and calculated that costs of US$300–420 billion 
would need to be met to achieve scale up over the 
years 2012–2030, representing 4%–8% of total annual 
health expenditure. This large investment in scaling 
up surgical services across 88 LMICs was positive when 
compared with the $12.3 trillion loss to economic growth 
in these countries if surgical service development was 
neglected. The Lancet Commission on Global Surgery 
data presented a similar picture presented to the Lancet 
Commission on Investing in Health—investing in surgical 
care was beneficial and produced significant economic 
returns on investment.
The few studies that have been published on the macro-
economic impact of surgical disease in LMICs all show 
significant costs to national economies.11 34 This study 
demonstrates significant estimated costs to the economy 
of Sierra Leone from untreated surgical disease. It is the 
first single-country study and also represents a move away 
from modelled data to the use of primary surgical data 
for an estimation of the economic impact of untreated 
disease. The economic impact of untreated surgical 
disease in Sierra Leone is significant. In 2012, the esti-
mated cumulative loss to the Sierra Leone economy 
from the unmet burden of surgical disease was between 
US$1.1 and US$3.8 billion, depending on the economic 
method used. This equates to between 23% and 100% 
of the 2012 GDP for Sierra Leone. Eighty per cent of 
Figure 1 Estimated discounted lifetime economic losses due to unmet surgery need by scenario. GNI, gross national income; 
ppp, purchasing power parity; VSL, value of a statistical life.
Table 5 Incremental losses averted by scale up of surgical provision compared with current met need
Incremental economic losses 
averted Scenario 2: 20% met need Scenario 3: 80% met need Scenario 4: 50% met need
GNI/capita (ppp) $191 900 891 $1 151 405 348 $671 653 120
Earnings forgone (LYL only) $60 154 488 $360 926 928 $210 540 708
Value of a statistical life approach $493 778 864 $2 962 673 184 $1 728 226 024
GNI, gross national income; LYL, life years lost; PPP, purchasing power parity.
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economic losses were due to mortality. The incremental 
losses averted by scale up of surgical provision to the 
Lancet Commission target of 80% were calculated to be 
between US$360 million and US$2.9 billion, accepting 
that the Lancet Commission target was for 80% access to 
the Bellwether procedures, not for all surgery.
There are a number of limitations to this study. First, 
we had to discard 46% of the surgical data because they 
Figure 2 One-way sensitivity analysis. DALYs, disability adjusted life years; GNI, gross national income; ppp, purchasing 
power parity; VSL, value of a statistical life.
Figure 3 Probabilistic sensitivity analysis. GNI, gross national income; ppp, purchasing power parity; VSL, value of a statistical 
life. 
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were incomplete. As a result, we worked with only 54% of 
the surgical data, which may not have been fully represen-
tative and may have skewed the results. We assumed that 
the 54% accounted for the 7.9% of met need and calcu-
lated unmet need based on this, although of course, if we 
had a full complement of data, the met need and hence 
the unmet need would have been significantly greater.
Where data were absent, for example when the age 
of patients was recorded but not their gender, we used 
complete data observations to weight how these were 
distributed across groups at the lowest level of aggregation 
available, for example, by age group. If observations were 
missing not at random (type 2 error), this could introduce 
bias into our estimates. We assumed operations not listed 
as either ‘emergency’ or ‘planned’ were planned, so as 
to create a conservative estimate of the overall economic 
impact. In practice, many of these may have been emer-
gencies and would have made the resulting economic 
losses even greater. We assumed that the same proportion 
of met and unmet need was uniform across all operations. 
However, it may be that the proportion of met: unmet 
need may be higher for certain operations because of the 
nature of the pathology and the urgency for example, 
free healthcare for pregnant women might mean that the 
ratio of met: unmet need is higher for caesarean sections 
than it is for emergency laparotomy. We also assumed that 
treating a treatable condition would return the patient 
back to full economic productivity, although this may not 
be the case.
There is substantial variation between estimates of 
economic losses depending on the methodology used, 
despite all methods using an equivalent estimate of DALYs 
attributable to unmet need. The VSL method places the 
greatest value on each DALY incurred and by definition 
leads to the largest estimate of economic loss. The human 
capital approaches, using estimates of GNI/capita and 
lifetime earnings foregone, place a small cost on the loss 
of each DALY and produce smaller estimates. In addition, 
economic losses estimated here do not consider the value 
of unpaid or domestic work because of uncertainty in 
assumptions required and because these do not form part 
of many estimates of GDP. In addition, our use of finan-
cial measurements of economic productivity is a limita-
tion in the largely agrarian economy of Sierra Leone. 
Other metrics, which cannot be easily valued in financial 
terms such as food insecurity or the distribution of labour 
within the household, may capture potentially important 
aspects of economic productivity. Omitting these factors 
makes our model more conservative and we are likely 
to underestimate total economic losses, with a greater 
underestimation occurring in female groups.
Averages (mean values) are used to parameterise the 
model, and we therefore do not account for heteroge-
neity in estimates except for between genders and the 
age at which surgery was required. Other literature has 
shown a notable correlation between propensity for ill 
health and income, particularly in low/middle-income 
contexts such as this study, and this model does not 
account for this. The lifetime earnings estimates in the 
human capital approach may overstate losses and there-
fore assume that premature mortality or morbidity causes 
a lifetime’s impact to the economy. With more data, we 
could have used a friction cost method to be more conser-
vative; however, the lost earnings estimates are the lowest 
produced in this study.
Despite these limitations which are prevalent in much 
of the global surgical literature, we have provided the first 
national study of economic losses based on as much data 
as is currently available for Sierra Leone. This suggests 
massive economic losses, much of which may be avert-
able by the provision of timely, surgical care. What is now 
required is the development of a costed national surgical 
plan as recently undertaken in Zambia. In the case of 
Sierra Leone, the necessary investment might be more 
than the Lancet Commission on Global Surgery figure 
of 4%–8% of total annual health expenditure as there is 
likely to be a large initial capital outlay as well as a very 
significant necessary investment in the surgical work-
force. Only then will we be able to compare this required 
investment with our economic loss figures to quantify 
the return on surgical system investment in terms of lives 
saves and disability averted.
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